Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
1 other identifier
observational
191
1 country
1
Brief Summary
Endoscopic submucosal dissection (ESD) is a minimally invasive alternative to esophagectomy for early esophageal squamous cell carcinoma (EESCC), The data of EESCC patients who received ESD or esophagectomy were retrospectively analyzed,The aim of this study was to compare the efficacy and safety of ESD and esophagectomy in EESCC,Risk factors affecting the prognosis of patients with early esophageal squamous cell carcinoma were analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedSeptember 29, 2023
September 1, 2023
10 years
June 15, 2023
September 27, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
overall survival (OS)
OS was measured from the date of ESD or esophagectomy until death from any cause
10 years
Disease specific survival (DSS)
DSS was measured from the date of ESD or esophagectomy until death resulting from ESCC
10 years
Recurrence free survival (RFS)
RFS was measured from the date of ESD or esophagectomy until the first recurrence or metastasis
10 years
Secondary Outcomes (5)
postoperative complications
30 days
R0 resection
15 days
adjuvant therapy
10 years
operation time
12 hours
Post-operative hospitalization days
30 days
Study Arms (2)
Endoscopic submucosal dissection
Early esophageal cancer patients treated with ESD
Esophagectomy
Early esophageal cancer patients treated with esophagectomy
Interventions
The patient was positioned in the left lateral decubitus position.Marking dots were made with a dual knife/hybrid knife around the lesion, and a solution of glycerin fructose with indigo carmine was injected into the submucosal layer to lift the lesion. Finally, after pre-cutting of the mucosal and submucosal layers around the lesion and dissection of the submucosa, the lesion was removed en bloc.
The main surgical methods of esophagectomy include the McKeown operation, Lvor-lewis, Sweet and minimally invasive radical resection of esophageal cancer (MIE)
Eligibility Criteria
Patients with early esophageal cancer from January 2011 to January 2021 admitted to Changhai Hospital were included in this study.Patients treated with ESD were classified as the ESD group, and those who underwent radical esophageal cancer treatment were classified as the surgical group.
You may qualify if:
- Mucosal or submucosal squamous cell carcinoma of the esophagus
- no lymph node involvement or distant metastasis on computed tomography (CT) or pathology;
You may not qualify if:
- Tis premalignant lesions (high-grade intraepithelial neoplasia;HGIN)
- patients with neoadjuvant therapy
- patients combined with severe diseases of other organs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Changhai Hospital, Naval Medical University
Shanghai, China
Related Publications (4)
Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, Yao L, Korrapati P, Jin XJ, Zhang YX, Xu MD, Zhou PH. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort. Clin Gastroenterol Hepatol. 2019 Jan;17(1):73-81.e3. doi: 10.1016/j.cgh.2018.04.038. Epub 2018 Apr 25.
PMID: 29704682BACKGROUNDAn W, Liu MY, Zhang J, Cui YP, Gao J, Wang LP, Chen Y, Yang LX, Chen HZ, Jin H, Liu F, Chen J, Li ZS, Wang LW, Shi XG, Sun C. Endoscopic submucosal dissection versus esophagectomy for early esophageal squamous cell carcinoma with tumor invasion to different depths. Am J Cancer Res. 2020 Sep 1;10(9):2977-2992. eCollection 2020.
PMID: 33042630BACKGROUNDLiu Z, Zhao R. Endoscopic Submucosal Dissection vs. Surgery for Superficial Esophageal Squamous Cancer: A Systematic Review and Meta-Analysis. Front Oncol. 2022 Apr 21;12:816832. doi: 10.3389/fonc.2022.816832. eCollection 2022.
PMID: 35530330BACKGROUNDQian M, Feng S, Zhou H, Chen L, Wang S, Zhang K. Endoscopic submucosal dissection versus esophagectomy for t1 esophageal squamous cell carcinoma: a propensity score-matched analysis. Therap Adv Gastroenterol. 2022 Nov 21;15:17562848221138156. doi: 10.1177/17562848221138156. eCollection 2022.
PMID: 36458047BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei An, Doctor
Changhai Hospital, Naval Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Gastroenterology,Changhai Hospital;Academician of Chinese Academy of Engineering
Study Record Dates
First Submitted
June 15, 2023
First Posted
September 29, 2023
Study Start
January 1, 2011
Primary Completion
January 1, 2021
Study Completion
January 1, 2023
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share